HCN1 and Cognitive impairment: DEEs are characterized by the presence of significant comorbidities, including developmental delay and cognitive impairments; and patients carrying the HCN1 p.G391D and p.M153I variants were reported to display severe and mild intellectual disability, respectively (Marini et al., 2018).